Attention Deficit Hyperactivity Disorder (ADHD) is a brain disorder marked by an ongoing pattern of inattention and/or hyperactivity-impulsivity that interferes with functioning or development. It may begin in early childhood and can continue into adulthood. Without treatment, ADHD can cause problems at home, at school, at work, and with relationships. In the past, ADHD was termed as Attention Deficit Disorder (ADD). The exact cause is not known, but ADHD tends to run in families. Boys are about three times more likely than girls to be diagnosed with it.
Access research report on global attention deficit hyperactivity disorder market: http://www.grandviewresearch.com/industry-analysis/attention-deficit-hyperactivity-disorder-adhd-market
There are three main types of ADHD symptoms:
Trouble paying attention– People with ADHD are easily distracted. They have a hard time focusing on any one task; Trouble sitting still for even a short time: This is called hyperactivity. Children with ADHD may squirm, fidget, or run around the wrong times. Teens and adults often feel restless and fidgety. They are not able to enjoy reading or performing other quiet activities; And Acting before thinking: People with ADHD may talk too loud, laugh too loud, or become angrier than the situation calls for. ADHD symptoms can appear as early as between the ages of 3 and 6 and thus ADHD is termed as neuro developmental disorder and can continue through adolescence and adulthood. ADHD symptoms can change over time as a person ages.
Related reports by Grand View Research:
The global ADHD therapeutics market is segmented on the basis of medication, age group, therapy, distribution channel, and region.
For many people, ADHD medications reduce hyperactivity and impulsivity and improve their ability to focus, work, and learn. On the basis of medication the market size covers Stimulants (Amphetamine, Methylphenidate, Dextroamphetamine, Dexmethylphenidate, and Lisdexamfetamine Dimesylate): Stimulant is the most common type of medication used for treating ADHD. It increases the brain chemicals dopamine and norepinephrine, which play important roles in thinking and attention; Non-stimulants (Atomoxetine, Bupropion, Guanfacine, and Clonidine): These medications take longer to start working than stimulants, but can also improve focus, attention, and impulsivity in a person with ADHD. Although not approved by the U.S. Food and Drug Administration (FDA) specifically for the treatment of ADHD, some antidepressants are sometimes used alone or in combination with a stimulant to treat ADHD.
Read Our Blogs – grandviewresearch.com/blogs/healthcare
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Corporate Sales Specialist, USA
Grand View Research, Inc
Toll Free: 1-888-202-9519
For More Information: www.grandviewresearch.com